Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study.

Lisspers K, Larsson K, Janson C, Ställberg B, Tsiligianni I, Gutzwiller FS, Mezzi K, Bjerregaard BK, Jorgensen L, Johansson G.

NPJ Prim Care Respir Med. 2019 Dec 10;29(1):45. doi: 10.1038/s41533-019-0157-3.

2.

A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden.

Sulku J, Janson C, Melhus H, Malinovschi A, Ställberg B, Bröms K, Högman M, Lisspers K, Hammarlund-Udenaes M, Nielsen EI.

Int J Chron Obstruct Pulmon Dis. 2019 Nov 5;14:2451-2460. doi: 10.2147/COPD.S218747. eCollection 2019.

3.

A multinational observational study identifying primary care patients at risk of overestimation of asthma control.

Kritikos V, Price D, Papi A, Infantino A, Ställberg B, Ryan D, Lavorini F, Chrystyn H, Haughney J, Lisspers K, Gruffydd-Jones K, Román Rodríguez M, Høegh Henrichsen S, van der Molen T, Carter V, Bosnic-Anticevich S.

NPJ Prim Care Respir Med. 2019 Dec 5;29(1):43. doi: 10.1038/s41533-019-0156-4.

4.

Errors in inhaler use related to devices and to inhalation technique among patients with chronic obstructive pulmonary disease in primary health care.

Lindh A, Theander K, Arne M, Lisspers K, Lundh L, Sandelowsky H, Ställberg B, Westerdahl E, Zakrisson AB.

Nurs Open. 2019 Aug 20;6(4):1519-1527. doi: 10.1002/nop2.357. eCollection 2019 Oct.

5.

Subjective swallowing symptoms and related risk factors in COPD.

Gonzalez Lindh M, Malinovschi A, Brandén E, Janson C, Ställberg B, Bröms K, Blom Johansson M, Lisspers K, Koyi H.

ERJ Open Res. 2019 Sep 25;5(3). pii: 00081-2019. doi: 10.1183/23120541.00081-2019. eCollection 2019 Jul.

6.

Different Relationships between FENO and COPD Characteristics in Smokers and Ex-Smokers.

Högman M, Thornadtsson A, Bröms K, Janson C, Lisspers K, Ställberg B, Hedenström H, Malinovschi A.

COPD. 2019 Aug;16(3-4):227-233. doi: 10.1080/15412555.2019.1638355. Epub 2019 Jul 29.

PMID:
31357875
7.

Factors associated with well-controlled asthma-A cross-sectional study.

Lindgren H, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J.

Allergy. 2020 Jan;75(1):208-211. doi: 10.1111/all.13976. Epub 2019 Aug 1. No abstract available.

PMID:
31298735
8.

Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.

Larsson K, Janson C, Ställberg B, Lisspers K, Olsson P, Kostikas K, Gruenberger JB, Gutzwiller FS, Uhde M, Jorgensen L, Johansson G.

Int J Chron Obstruct Pulmon Dis. 2019 May 13;14:995-1008. doi: 10.2147/COPD.S195382. eCollection 2019.

9.

Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease.

Åberg J, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J.

Int J Chron Obstruct Pulmon Dis. 2019 May 7;14:961-969. doi: 10.2147/COPD.S193311. eCollection 2019.

10.

Higher alveolar nitric oxide in COPD is related to poorer physical capacity and lower oxygen saturation after physical testing.

Högman M, Thornadtsson A, Bröms K, Janson C, Lisspers K, Ställberg B, Hedenström H, Malinovschi A.

Eur Respir J. 2019 Aug 1;54(2). pii: 1900263. doi: 10.1183/13993003.00263-2019. Print 2019 Aug. No abstract available.

PMID:
31073082
11.

Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.

Giezeman M, Hasselgren M, Lisspers K, Ställberg B, Montgomery S, Janson C, Sundh J.

Int J Chron Obstruct Pulmon Dis. 2018 Nov 28;13:3857-3865. doi: 10.2147/COPD.S175641. eCollection 2018.

12.

A complex intervention of self-management for patients with COPD or CHF in primary care improved performance and satisfaction with regard to own selected activities; A longitudinal follow-up.

Zakrisson AB, Arne M, Hasselgren M, Lisspers K, Ställberg B, Theander K.

J Adv Nurs. 2019 Jan;75(1):175-186. doi: 10.1111/jan.13899. Epub 2018 Nov 27.

PMID:
30375028
13.

Endothelial dysfunction is associated with impaired lung function in two independent community cohorts.

Rydell A, Janson C, Lisspers K, Ställberg B, Nowak C, Carlsson AC, Feldreich T, Iggman D, Lind L, Ärnlöv J.

Respir Med. 2018 Oct;143:123-128. doi: 10.1016/j.rmed.2018.09.009. Epub 2018 Sep 12.

PMID:
30261983
14.

Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients.

Ställberg B, Janson C, Larsson K, Johansson G, Kostikas K, Gruenberger JB, Gutzwiller FS, Jorgensen L, Uhde M, Lisspers K.

NPJ Prim Care Respir Med. 2018 Sep 10;28(1):33. doi: 10.1038/s41533-018-0101-y.

15.

 Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.

Janson C, Johansson G, Ställberg B, Lisspers K, Olsson P, Keininger DL, Uhde M, Gutzwiller FS, Jörgensen L, Larsson K.

Respir Res. 2018 Sep 10;19(1):172. doi: 10.1186/s12931-018-0868-y.

16.

Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).

Janson C, Lisspers K, Ställberg B, Johansson G, Telg G, Thuresson M, Nordahl Christensen H, Larsson K.

Respir Res. 2018 Sep 3;19(1):168. doi: 10.1186/s12931-018-0855-3.

17.

Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR).

Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K.

Eur Respir J. 2018 Aug 2;52(2). pii: 1701927. doi: 10.1183/13993003.01927-2017. Print 2018 Aug.

18.

Factors associated with lung cancer in COPD patients.

Sandelin M, Mindus S, Thuresson M, Lisspers K, Ställberg B, Johansson G, Larsson K, Janson C.

Int J Chron Obstruct Pulmon Dis. 2018 Jun 6;13:1833-1839. doi: 10.2147/COPD.S162484. eCollection 2018.

19.

What do patients know? Education from the European Lung Foundation perspective.

Powell P, Smyth D, Saraiva I, Lisspers K, Hardavella G, Fuertes J, Hill K.

Breathe (Sheff). 2018 Mar;14(1):30-35. doi: 10.1183/20734735.020217. Review.

20.

Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).

Lisspers K, Janson C, Larsson K, Johansson G, Telg G, Thuresson M, Ställberg B.

Respir Med. 2018 Mar;136:15-20. doi: 10.1016/j.rmed.2018.01.020. Epub 2018 Jan 31.

21.

Economic burden of COPD in a Swedish cohort: the ARCTIC study.

Lisspers K, Larsson K, Johansson G, Janson C, Costa-Scharplatz M, Gruenberger JB, Uhde M, Jorgensen L, Gutzwiller FS, Ställberg B.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 11;13:275-285. doi: 10.2147/COPD.S149633. eCollection 2018.

22.

2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.

Högman M, Sulku J, Ställberg B, Janson C, Bröms K, Hedenström H, Lisspers K, Malinovschi A.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 3;13:165-173. doi: 10.2147/COPD.S151016. eCollection 2018.

23.

Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).

Larsson K, Ställberg B, Lisspers K, Telg G, Johansson G, Thuresson M, Janson C.

Respir Res. 2018 Jan 18;19(1):12. doi: 10.1186/s12931-018-0719-x.

24.

Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD.

Stegberg M, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J.

Eur Clin Respir J. 2018 Jan 4;5(1):1421389. doi: 10.1080/20018525.2017.1421389. eCollection 2018.

25.

Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014.

Sundh J, Åberg J, Hasselgren M, Montgomery S, Ställberg B, Lisspers K, Janson C.

Eur Clin Respir J. 2017 Dec 4;4(1):1409060. doi: 10.1080/20018525.2017.1409060. eCollection 2017.

26.

Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.

Sundh J, Wireklint P, Hasselgren M, Montgomery S, Ställberg B, Lisspers K, Janson C.

Respir Med. 2017 Nov;132:154-160. doi: 10.1016/j.rmed.2017.10.010. Epub 2017 Oct 17.

27.

Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population.

Bjermer L, van Boven JFM, Costa-Scharplatz M, Keininger DL, Gutzwiller FS, Lisspers K, Mahon R, Olsson P, Roche N.

Respir Res. 2017 Dec 11;18(1):206. doi: 10.1186/s12931-017-0688-5.

28.

Pulmonary rehabilitation in COPD - available resources and utilization in Swedish primary and secondary care.

Sundh J, Lindgren H, Hasselgren M, Montgomery S, Janson C, Ställberg B, Lisspers K.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 8;12:1695-1704. doi: 10.2147/COPD.S135111. eCollection 2017.

29.

Use of electronic medical records and biomarkers to manage risk and resource efficiencies.

Ryan D, Blakey J, Chisholm A, Price D, Thomas M, Ställberg B, Lisspers K, Kocks JWH; Respiratory Effectiveness Group.

Eur Clin Respir J. 2017 Mar 14;4(1):1293386. doi: 10.1080/20018525.2017.1293386. eCollection 2017.

30.

The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP).

Masefield S, Edwards J, Hansen K, Hamerlijnck D, Lisspers K, van der Schee M, Silva L, Matthews J, Gaga M, Adcock I, Holgate S, Walker S, Powell P.

Eur Respir J. 2017 May 1;49(5). pii: 1602295. doi: 10.1183/13993003.02295-2016. Print 2017 May. No abstract available.

31.

Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, Lavorini F, Law LM, Lisspers K, Papi A, Ryan D, Ställberg B, van der Molen T, Chrystyn H.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1071-1081.e9. doi: 10.1016/j.jaip.2017.01.004. Epub 2017 Mar 9.

PMID:
28286157
32.

Call to action: improving primary care for women with COPD.

Tsiligianni I, Rodríguez MR, Lisspers K, LeeTan T, Infantino A.

NPJ Prim Care Respir Med. 2017 Feb 15;27(1):11. doi: 10.1038/s41533-017-0013-2. Review.

33.

Availability of pulmonary rehabilitation in primary care for patients with COPD: a cross-sectional study in Sweden.

Arne M, Emtner M, Lisspers K, Wadell K, Ställberg B.

Eur Clin Respir J. 2016 Nov 28;3:31601. doi: 10.3402/ecrj.v3.31601. eCollection 2016.

34.

The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG.

Ställberg B, Teixeira P, Blom C, Lisspers K, Tsiligianni I, Jordan R, Román M, Kleefstra N, Korzh O, Price D, Chavannes N.

NPJ Prim Care Respir Med. 2016 Nov 17;26:16069. doi: 10.1038/npjpcrm.2016.69. No abstract available.

35.

Change in health status in COPD: a seven-year follow-up cohort study.

Sundh J, Montgomery S, Hasselgren M, Kämpe M, Janson C, Ställberg B, Lisspers K.

NPJ Prim Care Respir Med. 2016 Oct 20;26:16073. doi: 10.1038/npjpcrm.2016.73.

36.

Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG.

Lisspers K, Teixeira P, Blom C, Kocks J, Ställberg B, Price D, Chavannes N.

NPJ Prim Care Respir Med. 2016 Apr 14;26:16016. doi: 10.1038/npjpcrm.2016.16. No abstract available.

37.

Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.

Jones RC, Price D, Chavannes NH, Lee AJ, Hyland ME, Ställberg B, Lisspers K, Sundh J, van der Molen T, Tsiligianni I; UNLOCK Group of the IPCRG.

NPJ Prim Care Respir Med. 2016 Apr 7;26:16010. doi: 10.1038/npjpcrm.2016.10.

38.

Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.

Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, Gruffydd-Jones K, Haughney J, Roche N, Lavorini F, Papi A, Infantino A, Roman-Rodriguez M, Bosnic-Anticevich S, Lisspers K, Ställberg B, Henrichsen SH, van der Molen T, Hutton C, Price DB.

J Asthma. 2016;53(3):321-9. doi: 10.3109/02770903.2015.1099160. Epub 2016 Jan 26.

39.

Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population.

Sundh J, Ställberg B, Lisspers K, Kämpe M, Janson C, Montgomery S.

COPD. 2016;13(1):57-65. doi: 10.3109/15412555.2015.1043426. Epub 2015 Sep 14.

PMID:
26367315
40.

Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study.

Lisspers K, Johansson G, Jansson C, Larsson K, Stratelis G, Hedegaard M, Ställberg B.

Respir Med. 2014 Sep;108(9):1345-54. doi: 10.1016/j.rmed.2014.06.002. Epub 2014 Jun 17.

41.

Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study.

Kruis AL, Ställberg B, Jones RC, Tsiligianni IG, Lisspers K, van der Molen T, Kocks JW, Chavannes NH.

PLoS One. 2014 Mar 5;9(3):e90145. doi: 10.1371/journal.pone.0090145. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e98725.

42.

Determinants of uncontrolled asthma in a Swedish asthma population: cross-sectional observational study.

Kämpe M, Lisspers K, Ställberg B, Sundh J, Montgomery S, Janson C.

Eur Clin Respir J. 2014 Sep 12;1. doi: 10.3402/ecrj.v1.24109. eCollection 2014.

43.

Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS).

Ställberg B, Janson C, Johansson G, Larsson K, Stratelis G, Telg G, Lisspers KH.

Prim Care Respir J. 2014 Mar;23(1):38-45. doi: 10.4104/pcrj.2013.00106.

44.

Management of COPD exacerbations in primary care: a clinical cohort study.

Sundh J, Österlund Efraimsson E, Janson C, Montgomery S, Ställberg B, Lisspers K.

Prim Care Respir J. 2013 Dec;22(4):393-9. doi: 10.4104/pcrj.2013.00087.

45.

Sex-differences in quality of life and asthma control in Swedish asthma patients.

Lisspers K, Ställberg B, Janson C, Johansson G, Svärdsudd K.

J Asthma. 2013 Dec;50(10):1090-5. doi: 10.3109/02770903.2013.834502. Epub 2013 Sep 25.

PMID:
23947390
46.

Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS).

Janson C, Larsson K, Lisspers KH, Ställberg B, Stratelis G, Goike H, Jörgensen L, Johansson G.

BMJ. 2013 May 29;346:f3306. doi: 10.1136/bmj.f3306. Erratum in: BMJ. 2013;346:f4375.

47.

Assessment of COPD in primary care: new evidence supports use of the DOSE index.

Sundh J, Montgomery S, Ställberg B, Lisspers K.

Prim Care Respir J. 2013 Jun;22(2):142-3. doi: 10.4104/pcrj.2013.00050. No abstract available.

48.

Hospital-based pulmonary rehabilitation in patients with COPD in Sweden--a national survey.

Wadell K, Janaudis Ferreira T, Arne M, Lisspers K, Ställberg B, Emtner M.

Respir Med. 2013 Aug;107(8):1195-200. doi: 10.1016/j.rmed.2013.04.019. Epub 2013 May 20.

49.

Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.

Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.

J Intern Med. 2013 Jun;273(6):584-94. doi: 10.1111/joim.12067. Epub 2013 Apr 1.

50.

Clinical COPD Questionnaire score (CCQ) and mortality.

Sundh J, Janson C, Lisspers K, Montgomery S, Ställberg B.

Int J Chron Obstruct Pulmon Dis. 2012;7:833-42. doi: 10.2147/COPD.S38119. Epub 2012 Dec 20.

Supplemental Content

Loading ...
Support Center